FIELD: medicine, dermatovenerology.
SUBSTANCE: one should perform diagnostics with the help of fluorescence spectrums of affected sections. Section being of own intensive fluorescence should be irradiated with light at wave length being 630±10 nm and energy density 10-4500 J/sq. cm, sections which has no own intensive fluorescence should be applied with an applicator containing 2-20% solution of 5-aminolevulinic acid and after exposure and applicator's removal they should be irradiated with light at wave length being 630±10 nm and energy density of 10-4500 sq. cm. The flow of irradiation process should be controlled due to fixing fluorescence spectrums at affected skin sections before irradiation, after the use of applicator that contains 5-aminolevulinic acid, after irradiation, moreover, irradiation should be stopped at decreased concentration of porhyrins being below therapeutic values. The innovation decreases cutaneous fatty secretion, quantity and density of eruption.
EFFECT: higher accuracy and efficiency of diagnostics and therapy.
8 cl, 4 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THERAPY AND CONTROL FOR THE PROCESS OF TREATING SCARS AS A RESULT OF ACNE VULGARIS | 2003 |
|
RU2252796C1 |
DEVICE AND METHOD OF FLUORESCENT DIAGNOSTICS AND PHOTODYNAMIC THERAPY OF SKIN DISEASES | 2008 |
|
RU2382660C1 |
METHOD OF PHOTODYNAMIC HEALING OF SEPTIC WOUNDS AND TROPHIC ULCERS | 2008 |
|
RU2395315C1 |
METHOD FOR APPLYING PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS | 1997 |
|
RU2147249C1 |
METHOD FOR PERSONIFIED PHOTODYNAMIC THERAPY OF EXTENSIVE COSMETIC SKIN DEFECTS | 2016 |
|
RU2625297C2 |
PREPARATION FOR PHOTODYNAMIC THERAPY | 1997 |
|
RU2146144C1 |
METHOD FOR NON-ONCOLOGIC COSMETIC SKIN DEFECTS PHOTODYNAMIC THERAPY | 2016 |
|
RU2621845C2 |
AGENT FOR FLUORESCENT DIAGNOSIS AND PHOTODYNAMIC THERAPY ON ONCOLOGICAL AND NON-ONCOLOGICAL DISEASES | 2002 |
|
RU2219921C1 |
OCTA-4,5-CARBOXYPHTHALOCYANINES AS PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 2000 |
|
RU2193563C2 |
METHOD OF DERMATOSIS DEVELOPMENT PREDICTION IN WOMEN WITH SCLEROPOLYCYSTIC OVARIAN SYNDROME (SPCO) | 2008 |
|
RU2367954C1 |
Authors
Dates
2005-12-10—Published
2003-09-03—Filed